Zeria Pharmaceutical Co., Ltd. 4559

TSE · Japan · Health Technology

¥1,903.00-48.00 (-2.46%)

Market open· Oct 2, 2026, 5:57 AM UTC· JPY · Data may be delayed

Company news

Yahoo FinanceJan 19, 2026

Underactive Bladder Syndrome Market to Observe Stunning Growth at a CAGR of 22.1% During the Forecast Period (2025-2034) | DelveInsight

DelveInsight's Underactive Bladder Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, underactive bladder syndrome emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets [the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, Japan, and China].

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.